Morgan Stanley’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$681K Buy
425,599
+386,125
+978% +$618K ﹤0.01% 5311
2025
Q1
$48.2K Sell
39,474
-17,918
-31% -$21.9K ﹤0.01% 6277
2024
Q4
$108K Buy
57,392
+13,663
+31% +$25.8K ﹤0.01% 6023
2024
Q3
$234K Buy
43,729
+30,843
+239% +$165K ﹤0.01% 5697
2024
Q2
$95.1K Buy
12,886
+913
+8% +$6.74K ﹤0.01% 5981
2024
Q1
$143K Sell
11,973
-38,474
-76% -$459K ﹤0.01% 5861
2023
Q4
$398K Buy
50,447
+43,197
+596% +$340K ﹤0.01% 5706
2023
Q3
$32K Sell
7,250
-2,810
-28% -$12.4K ﹤0.01% 6331
2023
Q2
$350K Buy
10,060
+2,024
+25% +$70.4K ﹤0.01% 5394
2023
Q1
$175K Buy
8,036
+3,278
+69% +$71.5K ﹤0.01% 5762
2022
Q4
$103K Buy
4,758
+1,631
+52% +$35.2K ﹤0.01% 5963
2022
Q3
$75K Buy
3,127
+609
+24% +$14.6K ﹤0.01% 6222
2022
Q2
$52K Sell
2,518
-108
-4% -$2.23K ﹤0.01% 6591
2022
Q1
$94K Buy
2,626
+616
+31% +$22.1K ﹤0.01% 6352
2021
Q4
$55K Sell
2,010
-9,736
-83% -$266K ﹤0.01% 6766
2021
Q3
$509K Buy
11,746
+5,514
+88% +$239K ﹤0.01% 5487
2021
Q2
$311K Buy
6,232
+5,052
+428% +$252K ﹤0.01% 5787
2021
Q1
$53K Sell
1,180
-70
-6% -$3.14K ﹤0.01% 6330
2020
Q4
$33K Buy
+1,250
New +$33K ﹤0.01% 6291
2020
Q2
Sell
-42
Closed -$1K 6688
2020
Q1
$1K Buy
+42
New +$1K ﹤0.01% 6476
2019
Q4
Sell
-2
Closed 6727
2019
Q3
$0 Sell
2
-191
-99% ﹤0.01% 6715
2019
Q2
$8K Buy
193
+132
+216% +$5.47K ﹤0.01% 6194
2019
Q1
$9K Hold
61
﹤0.01% 6210
2018
Q4
$5K Sell
61
-39
-39% -$3.2K ﹤0.01% 6295
2018
Q3
$16K Hold
100
﹤0.01% 6201
2018
Q2
$14K Hold
100
﹤0.01% 6230
2018
Q1
$14K Hold
100
﹤0.01% 6199
2017
Q4
$21K Buy
100
+2
+2% +$420 ﹤0.01% 6061
2017
Q3
$22K Sell
98
-35
-26% -$7.86K ﹤0.01% 5996
2017
Q2
$21K Hold
133
﹤0.01% 6070
2017
Q1
$57K Buy
133
+40
+43% +$17.1K ﹤0.01% 5792
2016
Q4
$45K Sell
93
-19
-17% -$9.19K ﹤0.01% 5778
2016
Q3
$76K Buy
112
+49
+78% +$33.3K ﹤0.01% 5417
2016
Q2
$34K Buy
+63
New +$34K ﹤0.01% 5665